Cargando…
Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites
HIV-1 subtypes and drug resistance are routinely tested by many international surveillance groups. However, results from different sites often vary. A systematic comparison of results from multiple sites is needed to determine whether a standardized protocol is required for consistent and accurate d...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912073/ https://www.ncbi.nlm.nih.gov/pubmed/27314585 http://dx.doi.org/10.1371/journal.pone.0157340 |
_version_ | 1782438212489183232 |
---|---|
author | Hora, Bhavna Keating, Sheila M. Chen, Yue Sanchez, Ana M. Sabino, Ester Hunt, Gillian Ledwaba, Johanna Hackett, John Swanson, Priscilla Hewlett, Indira Ragupathy, Viswanath Vikram Vemula, Sai Zeng, Peibin Tee, Kok-Keng Chow, Wei Zhen Ji, Hezhao Sandstrom, Paul Denny, Thomas N. Busch, Michael P. Gao, Feng |
author_facet | Hora, Bhavna Keating, Sheila M. Chen, Yue Sanchez, Ana M. Sabino, Ester Hunt, Gillian Ledwaba, Johanna Hackett, John Swanson, Priscilla Hewlett, Indira Ragupathy, Viswanath Vikram Vemula, Sai Zeng, Peibin Tee, Kok-Keng Chow, Wei Zhen Ji, Hezhao Sandstrom, Paul Denny, Thomas N. Busch, Michael P. Gao, Feng |
author_sort | Hora, Bhavna |
collection | PubMed |
description | HIV-1 subtypes and drug resistance are routinely tested by many international surveillance groups. However, results from different sites often vary. A systematic comparison of results from multiple sites is needed to determine whether a standardized protocol is required for consistent and accurate data analysis. A panel of well-characterized HIV-1 isolates (N = 50) from the External Quality Assurance Program Oversight Laboratory (EQAPOL) was assembled for evaluation at seven international sites. This virus panel included seven subtypes, six circulating recombinant forms (CRFs), nine unique recombinant forms (URFs) and three group O viruses. Seven viruses contained 10 major drug resistance mutations (DRMs). HIV-1 isolates were prepared at a concentration of 10(7) copies/ml and compiled into blinded panels. Subtypes and DRMs were determined with partial or full pol gene sequences by conventional Sanger sequencing and/or Next Generation Sequencing (NGS). Subtype and DRM results were reported and decoded for comparison with full-length genome sequences generated by EQAPOL. The partial pol gene was amplified by RT-PCR and sequenced for 89.4%-100% of group M viruses at six sites. Subtyping results of majority of the viruses (83%-97.9%) were correctly determined for the partial pol sequences. All 10 major DRMs in seven isolates were detected at these six sites. The complete pol gene sequence was also obtained by NGS at one site. However, this method missed six group M viruses and sequences contained host chromosome fragments. Three group O viruses were only characterized with additional group O-specific RT-PCR primers employed by one site. These results indicate that PCR protocols and subtyping tools should be standardized to efficiently amplify diverse viruses and more consistently assign virus genotypes, which is critical for accurate global subtype and drug resistance surveillance. Targeted NGS analysis of partial pol sequences can serve as an alternative approach, especially for detection of low-abundance DRMs. |
format | Online Article Text |
id | pubmed-4912073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49120732016-07-06 Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites Hora, Bhavna Keating, Sheila M. Chen, Yue Sanchez, Ana M. Sabino, Ester Hunt, Gillian Ledwaba, Johanna Hackett, John Swanson, Priscilla Hewlett, Indira Ragupathy, Viswanath Vikram Vemula, Sai Zeng, Peibin Tee, Kok-Keng Chow, Wei Zhen Ji, Hezhao Sandstrom, Paul Denny, Thomas N. Busch, Michael P. Gao, Feng PLoS One Research Article HIV-1 subtypes and drug resistance are routinely tested by many international surveillance groups. However, results from different sites often vary. A systematic comparison of results from multiple sites is needed to determine whether a standardized protocol is required for consistent and accurate data analysis. A panel of well-characterized HIV-1 isolates (N = 50) from the External Quality Assurance Program Oversight Laboratory (EQAPOL) was assembled for evaluation at seven international sites. This virus panel included seven subtypes, six circulating recombinant forms (CRFs), nine unique recombinant forms (URFs) and three group O viruses. Seven viruses contained 10 major drug resistance mutations (DRMs). HIV-1 isolates were prepared at a concentration of 10(7) copies/ml and compiled into blinded panels. Subtypes and DRMs were determined with partial or full pol gene sequences by conventional Sanger sequencing and/or Next Generation Sequencing (NGS). Subtype and DRM results were reported and decoded for comparison with full-length genome sequences generated by EQAPOL. The partial pol gene was amplified by RT-PCR and sequenced for 89.4%-100% of group M viruses at six sites. Subtyping results of majority of the viruses (83%-97.9%) were correctly determined for the partial pol sequences. All 10 major DRMs in seven isolates were detected at these six sites. The complete pol gene sequence was also obtained by NGS at one site. However, this method missed six group M viruses and sequences contained host chromosome fragments. Three group O viruses were only characterized with additional group O-specific RT-PCR primers employed by one site. These results indicate that PCR protocols and subtyping tools should be standardized to efficiently amplify diverse viruses and more consistently assign virus genotypes, which is critical for accurate global subtype and drug resistance surveillance. Targeted NGS analysis of partial pol sequences can serve as an alternative approach, especially for detection of low-abundance DRMs. Public Library of Science 2016-06-17 /pmc/articles/PMC4912073/ /pubmed/27314585 http://dx.doi.org/10.1371/journal.pone.0157340 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Hora, Bhavna Keating, Sheila M. Chen, Yue Sanchez, Ana M. Sabino, Ester Hunt, Gillian Ledwaba, Johanna Hackett, John Swanson, Priscilla Hewlett, Indira Ragupathy, Viswanath Vikram Vemula, Sai Zeng, Peibin Tee, Kok-Keng Chow, Wei Zhen Ji, Hezhao Sandstrom, Paul Denny, Thomas N. Busch, Michael P. Gao, Feng Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites |
title | Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites |
title_full | Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites |
title_fullStr | Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites |
title_full_unstemmed | Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites |
title_short | Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites |
title_sort | genetic characterization of a panel of diverse hiv-1 isolates at seven international sites |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912073/ https://www.ncbi.nlm.nih.gov/pubmed/27314585 http://dx.doi.org/10.1371/journal.pone.0157340 |
work_keys_str_mv | AT horabhavna geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT keatingsheilam geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT chenyue geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT sanchezanam geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT sabinoester geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT huntgillian geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT ledwabajohanna geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT hackettjohn geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT swansonpriscilla geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT hewlettindira geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT ragupathyviswanath geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT vikramvemulasai geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT zengpeibin geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT teekokkeng geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT chowweizhen geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT jihezhao geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT sandstrompaul geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT dennythomasn geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT buschmichaelp geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT gaofeng geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites AT geneticcharacterizationofapanelofdiversehiv1isolatesatseveninternationalsites |